(S)-(+)-Carvone

CAS No. 2244-16-8

(S)-(+)-Carvone( —— )

Catalog No. M18261 CAS No. 2244-16-8

(S)-(+)-Carvone is the main constituent of caraway oil and pineapple seed oil.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
500MG 26 In Stock
1G 27 In Stock

Biological Information

  • Product Name
    (S)-(+)-Carvone
  • Note
    Research use only, not for human use.
  • Brief Description
    (S)-(+)-Carvone is the main constituent of caraway oil and pineapple seed oil.
  • Description
    (S)-(+)-Carvone is the main constituent of caraway oil and pineapple seed oil.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2244-16-8
  • Formula Weight
    150.22
  • Molecular Formula
    C10H14O
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (665.69 mM)
  • SMILES
    CC1=CC[C@@H](CC1=O)C(=C)C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Chen D, et al. A Concise, Efficient and Scalable Total Synthesis of Thapsigargin and Nortrilobolide from (R)-(-)-Carvone. J Am Chem Soc. 2017 May 3;139(17):6046-6049.
molnova catalog
related products
  • Curculigoside B

    Curculigoside B shows antioxidative and antiosteoporotic activities, it can decrease area of bone resorption pit, osteoclastic formation and TRAP activity.

  • Sanggenol L

    Sanggenol L shows higher cytotoxicity against human oral tumor cell lines (HSC-2 and HSG) than against normal human gingival fibroblasts (HGF), it induces apoptosis via caspase activation and inhibition of NF-κB/IκBα± phosphorylation as a potent chemotherapeutic agent for ovarian cancers.

  • Labetalone hydrochlo...

    Labetalone hydrochloride is an impurity of Labetalol. Labetalol is an orally active adrenoceptor blocking drug, Labetalol is a competitive antagonist at both alpha- and beta-adrenoceptor sites.